← Open Payments lookup

SHERITA WILLIS: Open Payments

NPI 1740326610 · OSCEOLA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$275 in 9 payments from 7 companies in 2025. Trend: 2023 $270 · 2024 $313 · 2025 $275

Food & beverage: $275
CompanyPaymentsAmount
Lilly USA, LLC1$94
ABBVIE INC.3$71
Sumitomo Pharma America, Inc.1$29
Novo Nordisk Inc1$24
E.R. Squibb & Sons, L.L.C.1$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17

Products named: LINZESS, GEMTESA, Ozempic, COBENFY, VIBERZI, XIFAXAN, CAPLYTA.

Industry payments across AR — which companies pay providers there.